Tranche Update on Dong-A ST Co., Ltd.'s Equity Buyback Plan announced on January 26, 2023.
April 26, 2023 at 12:13 am
Share
From April 1, 2023 to April 25, 2023, the company has repurchased 9,713 shares, representing 0.11% for KRW 552.65 million. With this, the company has completed the repurchase of 40,519 shares, representing 0.47% for KRW 2,405.93 million under the buyback announced on January 26, 2023.
Dong-A ST Co Ltd is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company is involved of the manufacturing and sale of gastric mucosal protective agents, antihistamines, ischemic modifiers, antithrombotic agents, functional dyspepsia, hyperlipidemia, growth hormone, peptic ulcer treatments, cerebral metabolism improvement and hypertension treatments. It produces and sells diagnostic reagents for hepatitis E, I, A and B. In addition, it is engaged in the production and sale of medical devices including implants for artificial joint and maxillofacial surgery. The Company distributes its products in domestic and overseas markets such as Brazil, Turkey and Cambodia.
DONG-A ST CO., LTD. 